New insights into the antibacterial mechanism of action of squalamine

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 8, 2010, Pages 1688-1693

  Alhanout, Kamel ^a   Malesinki, Soazig ^b   Vidal, Nicolas ^b   Peyrot, Vincent ^b   Rolain, Jean Marc ^a   Brunel, Jean Michel ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Aminosterols; Depolarization; Detergent like mechanism of action

Indexed keywords

COLISTIN; SQUALAMINE; TOBRAMYCIN; ANTIINFECTIVE AGENT; CHOLESTANOL;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL OUTER MEMBRANE; CELL DEATH; CELL STRUCTURE; DEPOLARIZATION; DRUG SENSITIVITY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROSCOPY; TIME; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; CHOLESTANOLS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY; MICROSCOPY, ELECTRON, TRANSMISSION; TIME FACTORS;

EID: 77954708154     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq213     Document Type: Article

References (20)

1. Kaier K, Wilson C, Chalkley M et al. Health and economic impacts of antibiotic resistance in European hospitals-outlook on the BURDEN project. Infection 2008; 36: 492-4.
2. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64 Suppl 1: i3-10.
3. Moore KS, Wehrli S, Roder H et al. Squalamine: an aminosterol antibiotic from the shark. Proc Natl Acad Sci USA 1993; 90: 1354-8.
4. Wehrli SL, Moore KS, Roder H et al. Structure of the novel steroidal antibiotic squalamine determined by two-dimensional NMR spectroscopy. Steroids 1993; 58: 370-8.
5. Brunel JM, Salmi C, Loncle C et al. Squalamine: a polyvalent drug of the future? Curr Cancer Drug Targets 2005; 5: 267-72.
6. Salmi C, Brunel JM. Therapeutic potential of cationic steroid antibacterials. Expert Opin Investig Drugs 2007; 16: 1143-57.
7. Alhanout K, Brunel JM, Raoult D et al. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis. J Antimicrob Chemother 2009; 64: 810-4.
8. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
9. Salmi C, Loncle C, Vidal N et al. Squalamine: an appropriate strategy against the emergence of multidrug resistant Gram-negative bacteria? PLoS ONE 2008; 3: e2765.
10. Zavascki AP, Goldani LZ, Li J et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007; 60: 1206-15.
11. Li J, Nation RL, Milne RW et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents 2005; 25: 11-25.
12. Koike M, Iida K, Matsuo T. Electron microscopic studies on mode of action of polymyxin. J Bacteriol 1969; 97: 448-52.
13. Oh JT, Cajal Y, Skowronska EM et al. Cationic peptide antimicrobials induce selective transcription of micF and osmY in Escherichia coli. Biochim Biophys Acta Biomembr 2000; 1463: 43-54.
14. Oh JT, Van Dyk TK, Cajal Y et al. Osmotic stress in viable Escherichia coli as the basis for the antibiotic response by polymyxin B. Biochem Biophys Res Commun 1998; 246: 619-23.
15. Mortensen NP, Fowlkes J, Sullivan CJ et al. Effects of colistin on surface ultrastructure and nanomechanics of Pseudomonas aeruginosa cells. Langmuir 2009; 25: 3728-33.
16. Di PE, Salmi-Smail C, Brunel JM et al. Biophysical studies of the interaction of squalamine and other cationic amphiphilic molecules with bacterial and eukaryotic membranes: importance of the distribution coefficient in membrane selectivity. Chem Phys Lipids 2010; 163: 131-40.
17. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19: 491-511.
18. Hawkey PM. Pre-clinical experience with daptomycin. J Antimicrob Chemother 2008; 62 Suppl 3: iii7-14.
19. Lars R, Ata J. The effect of the ionophore valinomycin on biomimetic solid supported lipid DPPTE/EPC membranes. Bioelectrochem 2007; 70: 387-93.
20. Baltz RH. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering. Curr Opin Chem Biol 2009; 13: 144-51.